Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

SG&A

Share-based compensation expense

Asset impairment and restructuring costs

Expected credit losses on financial assets and related charges

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Canopy Growth

Canopy Growth Corp. engages in the production and sale of medical cannabis. The firm operates through the following segments: Global Cannabis and Other Consumer Products. The Global Cannabis segment encompasses the production, distribution and sale of a diverse range of cannabis and cannabinoid-based consumer products in Canada and internationally pursuant to applicable international and domestic legislation, regulations and permits. The Other Consumer Products segment encompasses the production, distribution and sale of consumer products by Storz & Bickel, This Works, BioSteel, and other ancillary revenue sources. It focuses on the treatment of chronic pain, seizures, muscle spasms, nausea, and loss of appetite. The company was founded by Bruce Linton on August 5, 2009 and is headquartered in Smith Falls, Canada.

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Earnings data Q2 2025

Earnings data Q3 2025

Revenue

Cost of revenue

Gross profit

Operating expenses

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Canopy Growth Corp. engages in the production, distribution, and sale of cannabis and cannabinoid-based products for both adult-use and medical purposes. The firm operates through the following segments: Canada Cannabis, Rest-of-world Cannabis, Storz and Bickel, BioSteel, This Works, and Other. The Canada Cannabis segment includes the production, distribution, and sale of cannabis, hemp, and cannabis products in Canada. The Rest-of-world Cannabis segment focuses on production and sale of cannabis, hemp, and cannabis products internationally. The Storz and Bickel segment produces and sells vaporizers. The BioSteel segment refers to the sale of consumer packaged goods including sports nutrition beverages, hydration mixes, proteins, and other specialty nutrition products. The This Works segment includes the production and sale of beauty, skincare, wellness, and sleep products, some of which have been blended with hemp-derived CBD isolate. The company was founded by Bruce Linton on August 5, 2009 and is headquartered in Smith Falls, Canada.

The coronavirus pandemic has been extremely ugly for the legal marijuana sector and CGC stock failed to escape the downfall. Nevertheless, shareholders should count their blessings.

Canopy Growth Shareholders Should Keep Things in Perspective

Aurora Cannabis

Aphria

Cronos Group

HEXO Corp

OrganiGram Holdings Inc.

Tilray Brands

Cannabis stocks in general stumbled in the latter half of last year. Wall Street expects profits, and none of these companies is anywhere near profitability.

Cannabis Stocks’ Short Interest Up in Smoke

The fact that smoking is a key risk factor for dying from coroavirus will hurt CGC stock. The company is facing other difficulties as well.

Smokers’ Susceptibility to the Coronavirus Will Hurt CGC Stock

One caveat, though: Much of this was due to stocking up before the start of the coronavirus "stay at home" order issued by the state.

Oregon Records Highest-Ever Monthly Marijuana Sales

These companies have deep pockets and aren't in danger of running out of cash anytime soon.

2 Pot Stocks Set To Survive the Coronavirus Pandemic

In yet another reversal, the government of the Canadian province issued an emergency order letting dispensaries operate during the COVID-19 shutdown.

Ontario Cannabis Shops Get the Go-Ahead to Reopen

Curaleaf Holdings, Inc.

Green Thumb Industries Inc.

GW Pharmaceuticals

Innovative Industrial Properties

Trulieve Cannabis Corp.

Previous highfliers Aurora Cannabis and Tilray no longer make the list.

Marijuana's Billion-Dollar Pot Stocks: Only 7 Remain

If you thought things couldn't possibly get worse for Canadian marijuana stocks, think again.

The Coronavirus Just Gut-Punched Canadian Pot Stocks

Beyond Meat

Pinterest

Plug Power

In 2019, I picked seven stocks that could double and four of them did. So, here are my potential 100%-upside picks for 2020.

5 Stocks That Could Double in 2020

Snap

Block

Trade Desk

These five growth stocks are in a great position to shake off coronavirus headwinds and stage huge comebacks in the second-half of 2020.

5 Growth Stocks to Buy for 2020

CGC stock still looks like the pick in cannabis. Recent developments show why, and support what appears to be a bottom in the stock.

Canopy Growth Stock Finally Has Some Good News

The adult-beverage giant is excited about something new from its cannabis partner.

Does Canopy Growth Have a Game-Changer? Constellation Brands Thinks So.

Netflix

Visa

These businesses will continue to see demand for their products and services even as people stay indoors.

3 Stocks to Buy During the Coronavirus Pandemic

CannTrust Holdings

Cannabis investors should expect a bumpy ride.

There Are Big Changes Coming to the Cannabis Industry in 2020

The company will temporarily let go of 200 employees while aiming to open company-owned retail stores.

Canopy Growth Announces Worker Furloughs, Dispensary Reopenings

The decision is an about-face from a province that formerly considered the stores to be "essential."

Coronavirus Forces Closure of Ontario Pot Dispensaries

The company's Storz & Bickel unit now has the green light to legally sell its Volcano Medic 2 device.

Canopy Growth Wins Canadian Medical-Device License for Pot Vaporizer

The pair are seasoned executives with years of experience in Canadian companies.

Canopy Growth Names 2 New Board Members

Which stock wins in this cannabis version of David vs. Goliath?

Better Buy:  OrganiGram Holdings vs.  Canopy Growth

As one of the most stable cannabis plays and with prices so low, CGC stock is well worth a gamble.
The post CGC Stock Is a COVID-19 Quarantine Winner appeared first on InvestorPlace.

CGC Stock Is a COVID-19 Quarantine Winner

Amplify Seymour Cannabis ETF

Amplify Alternative Harvest ETF

Global X Cannabis ETF

AXS Cannabis ETF

Cambria Cannabis ETF

AdvisorShares Pure Cannabis ETF 

Cannabis In The Time Of Corona With Bruce Linton (Podcast Transcript)

This marijuana stock is cheaper than it has been in a long time, but the market is also more volatile.

Is Canopy Growth Stock a Buy (CGC) ?

The cannabis industry faced significant challenges before the coronavirus erupted. But with the pandemic bringing everything to a halt, CGC stock is simply not worth the risk.

The Coronavirus Is the Latest Obstacle for CGC Stock

Even on a good day for the market, cannabis stocks didn't show much optimism.

Have Marijuana Investors Just Given Up?

Cannabis In The Time Of Corona With Bruce Linton (Podcast)

News for Canopy Growth Stock (CGC)